Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$380,512
-$68,627 QoQ
Shares Held
15,802
-1.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,943
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Nadler Financial Group, Inc. holds $7,548,194 across 7 Drug Manufacturers - General names. PFE ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,767 | $2,119,392 | |
| 2 | ABBV |
AbbVie Inc.
|
7,729 | $1,944,925 | |
| 3 | JNJ |
Johnson & Johnson
|
6,146 | $1,560,899 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,005 | $771,642 | |
| 5 | AMGN |
Amgen Inc
|
1,389 | $502,984 | |
| 6 | PFE |
Pfizer Inc
This page
|
15,802 | $380,512 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,120 | $267,840 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $380,512 | 15,802 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $449,139 | 15,995 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $414,634 | 16,652 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $538,519 | 21,135 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $595,261 | 24,557 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $667,810 | 26,354 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $668,794 | 25,209 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $808,352 | 27,932 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $767,015 | 27,413 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $760,599 | 27,409 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $783,289 | 27,207 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $959,243 | 28,919 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,096,328 | 29,889 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,223,632 | 29,991 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $1,586,646 | 30,965 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $1,354,109 | 30,944 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,685,519 | 32,148 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $1,663,473 | 32,132 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,918,180 | 32,484 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $1,430,727 | 33,265 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $1,288,559 | 32,905 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $1,234,247 | 34,067 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $1,255,625 | 34,111 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,159,388 | 31,591 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $901,147 | 27,558 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $915,648 | 28,053 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||